Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Biodiversity Data Journal|January 1, 2024
Xicotli Data: a project to retrieve plant-bee interactions from citizen scienceJuan M Barrios, Brenda Y Bedolla-García, Paola A González-Vanegas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 25, 2023
Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal CellsMatthew J Zunitch, Adam S Fisch, Brian Lin, et al.
Frontiers in Oncology|May 30, 2023
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancerMaroun Bou Zerdan, Prashanth Ashok Kumar, Dulce M Barrios, et al.
Journal of Medicinal Chemistry|February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cellsStephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.
Breast Cancer Research and Treatment|July 3, 2020
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancerDiana G Wang, Dulce M Barrios, Victoria S Blinder, et al.
Nature Medicine|May 22, 2012
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and targetAnjan Debnath, Derek Parsonage, Rosa M Andrade, et al.
The Oncologist|September 2, 2024
Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational studyFernando Sabino Marques Monteiro, Antonio Machado Alencar Junior, Karine Martins da Trindade, et al.
The Review of Scientific Instruments|November 7, 2012
Measurement of electron temperature of imploded capsules at the National Ignition FacilityN Izumi, T Ma, M Barrios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2021
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapiesD M Barrios, G S Phillips, A N Geisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J Kwiatkowski, Toni K Choueiri, André P Fay, et al.
Pageof 31